 intens weekli chemotherapi treatment extensive-stag small-cel lung cancer regimen cisplatin vincristin doxorubicin code dose intens drug comparison standard regimen cyclophosphamid doxorubicin vincristin cav etoposide-cisplatin EP extensive-stag small-cel lung cancer sclc dose intens frequent treatment dose size structur outpati protocol weekli administr chemotherapi altern myelosuppress nonmyelosuppress treatment support corticosteroid gastroprotect agent prophylact antibiot durat chemotherapi brief week total cumul dose drug similar standard regimen patient residu diseas chest chemotherapi thorac irradi patient complet respons cr prophylact cranial irradi elig extensive-stag sclc patient ambulatori year age free brain metastasi forty-eight extensive-stag sclc patient forty-f CR consolid thorac irradi CR rate median time progress week median surviv week surviv rate common site first relaps brain patient toxic overal toxic accept outpati regimen code regimen palli remiss extensive-stag sclc patient durabl remiss patient result pilot studi phase iii trial code standard cav EP chemotherapi